BioCardia’s heart failure cell therapy moves closer in Japan
BioCardia, a regenerative medicine company, is advancing its CardiAMP cell therapy for ischemic heart failure in Japan. The treatment uses a patient's own cells and is delivered via catheter. BioCardia's technology includes precision medicine and proprietary delivery systems.


